Cervical Cancer Screening Recommendations: Now and for the Future

Cervical cancer is the fourth most common cancer worldwide, with over 600,000 new cases annually and approximately 350,000 cancer-related deaths per year. The disease burden is disproportionately distributed, with cancer-related mortality ranging from 5.2 deaths per 100,000 individuals in highly-dev...

Descripción completa

Detalles Bibliográficos
Autores principales: Rayner, Marissa, Welp, Annalyn, Stoler, Mark H., Cantrell, Leigh A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10454304/
https://www.ncbi.nlm.nih.gov/pubmed/37628471
http://dx.doi.org/10.3390/healthcare11162273
_version_ 1785096159497289728
author Rayner, Marissa
Welp, Annalyn
Stoler, Mark H.
Cantrell, Leigh A.
author_facet Rayner, Marissa
Welp, Annalyn
Stoler, Mark H.
Cantrell, Leigh A.
author_sort Rayner, Marissa
collection PubMed
description Cervical cancer is the fourth most common cancer worldwide, with over 600,000 new cases annually and approximately 350,000 cancer-related deaths per year. The disease burden is disproportionately distributed, with cancer-related mortality ranging from 5.2 deaths per 100,000 individuals in highly-developed countries, to 12.4 deaths per 100,000 in less-developed countries. This article is a review of the current screening recommendations and potential future recommendations.
format Online
Article
Text
id pubmed-10454304
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-104543042023-08-26 Cervical Cancer Screening Recommendations: Now and for the Future Rayner, Marissa Welp, Annalyn Stoler, Mark H. Cantrell, Leigh A. Healthcare (Basel) Review Cervical cancer is the fourth most common cancer worldwide, with over 600,000 new cases annually and approximately 350,000 cancer-related deaths per year. The disease burden is disproportionately distributed, with cancer-related mortality ranging from 5.2 deaths per 100,000 individuals in highly-developed countries, to 12.4 deaths per 100,000 in less-developed countries. This article is a review of the current screening recommendations and potential future recommendations. MDPI 2023-08-11 /pmc/articles/PMC10454304/ /pubmed/37628471 http://dx.doi.org/10.3390/healthcare11162273 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Rayner, Marissa
Welp, Annalyn
Stoler, Mark H.
Cantrell, Leigh A.
Cervical Cancer Screening Recommendations: Now and for the Future
title Cervical Cancer Screening Recommendations: Now and for the Future
title_full Cervical Cancer Screening Recommendations: Now and for the Future
title_fullStr Cervical Cancer Screening Recommendations: Now and for the Future
title_full_unstemmed Cervical Cancer Screening Recommendations: Now and for the Future
title_short Cervical Cancer Screening Recommendations: Now and for the Future
title_sort cervical cancer screening recommendations: now and for the future
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10454304/
https://www.ncbi.nlm.nih.gov/pubmed/37628471
http://dx.doi.org/10.3390/healthcare11162273
work_keys_str_mv AT raynermarissa cervicalcancerscreeningrecommendationsnowandforthefuture
AT welpannalyn cervicalcancerscreeningrecommendationsnowandforthefuture
AT stolermarkh cervicalcancerscreeningrecommendationsnowandforthefuture
AT cantrellleigha cervicalcancerscreeningrecommendationsnowandforthefuture

Ejemplares similares